These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 62019)

  • 1. Lysis of RNA tumor viruses by human serum: direct antibody-independent triggering of the classical complement pathway.
    Cooper NR; Jensen FC; Welsh RM; Oldstone MB
    J Exp Med; 1976 Oct; 144(4):970-84. PubMed ID: 62019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human serum lyses RNA tumour viruses.
    Welsh RM; Cooper NR; Jensen FC; Oldstone MB
    Nature; 1975 Oct; 257(5527):612-4. PubMed ID: 170540
    [No Abstract]   [Full Text] [Related]  

  • 3. Lysis of oncornaviruses by human serum. Isolation of the viral complement (C1) receptor and identification as p15E.
    Bartholomew RM; Esser AF; Müller-Eberhard HJ
    J Exp Med; 1978 Mar; 147(3):844-53. PubMed ID: 632750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody-independent activation of C1. II. Evidence for two classes of nonimmune activators of the classical pathway of complement.
    Peitsch MC; Kovacsovics TJ; Tschopp J; Isliker H
    J Immunol; 1987 Mar; 138(6):1871-6. PubMed ID: 3029223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of antibody-independent activation of the first component of complement (Cl) on retrovirus membranes.
    Bartholomew RM; Esser AF
    Biochemistry; 1980 Jun; 19(13):2847-53. PubMed ID: 6772208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human immunodeficiency virus type 1 activates the classical pathway of complement by direct C1 binding through specific sites in the transmembrane glycoprotein gp41.
    Ebenbichler CF; Thielens NM; Vornhagen R; Marschang P; Arlaud GJ; Dierich MP
    J Exp Med; 1991 Dec; 174(6):1417-24. PubMed ID: 1744579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of killing of Giardia lamblia trophozoites by complement.
    Deguchi M; Gillin FD; Gigli I
    J Clin Invest; 1987 May; 79(5):1296-302. PubMed ID: 3646264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Requirement for the alternative pathway as well as C4 and C2 in complement-dependent hemolysis via the lectin pathway.
    Suankratay C; Zhang XH; Zhang Y; Lint TF; Gewurz H
    J Immunol; 1998 Mar; 160(6):3006-13. PubMed ID: 9510205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C1 subcomponent complexes: basic and clinical aspects.
    Laurell AB; Sjöholm AG
    Behring Inst Mitt; 1993 Dec; (93):292-8. PubMed ID: 8172579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of human complement serine-proteinase C1r is down-regulated by a Ca(2+)-dependent intramolecular control that is released in the C1 complex through a signal transmitted by C1q.
    Thielens NM; Illy C; Bally IM; Arlaud GJ
    Biochem J; 1994 Jul; 301 ( Pt 2)(Pt 2):509-16. PubMed ID: 8042996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The unactivated form of the first component of human complement, C1.
    Gigli I; Porter RR; Sim RB
    Biochem J; 1976 Sep; 157(3):541-8. PubMed ID: 985398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in activation of human and guinea pig complement by retroviruses.
    Bartholomew RM; Esser AF
    J Immunol; 1978 Nov; 121(5):1748-51. PubMed ID: 213489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trinitrophenylated red cells (E-TNP) as a model for antibody-independent activation of the complement system via the classical pathway.
    Loos M; Thesen R
    J Immunol; 1978 Jul; 121(1):24-8. PubMed ID: 670702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of selective complement deficiency on the rate of neutralization of enveloped viruses by human sera.
    Leddy JP; Simons RL; Douglas RG
    J Immunol; 1977 Jan; 118(1):28-34. PubMed ID: 187701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular accumulation of oncornaviruses in continous human cell lines.
    Zhdanov VM; Lozinsky TF; Volkova MY; Abenova UA; Mazurenko NN; Miller GG; Ilyin KV; Irlin IS; Klimenko SM; Bykovsky AF
    Neoplasma; 1974; 21(3):257-65. PubMed ID: 4138099
    [No Abstract]   [Full Text] [Related]  

  • 16. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
    Brown EJ; Ramsey J; Hammer CH; Frank MM
    J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody-independent killing of gram-negative bacteria via the classical pathway.
    Clas F; Loos M
    Behring Inst Mitt; 1984 Nov; (76):59-74. PubMed ID: 6525148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the classical pathway of complement by Hageman factor fragment.
    Ghebrehiwet B; Silverberg M; Kaplan AP
    J Exp Med; 1981 Mar; 153(3):665-76. PubMed ID: 7252410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demonstration and quantitation of activation of the first component of complement in human serum.
    Ziccardi RJ; Cooper NR
    J Exp Med; 1978 Feb; 147(2):385-95. PubMed ID: 75238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human astrovirus coat protein binds C1q and MBL and inhibits the classical and lectin pathways of complement activation.
    Hair PS; Gronemus JQ; Crawford KB; Salvi VP; Cunnion KM; Thielens NM; Arlaud GJ; Rawal N; Krishna NK
    Mol Immunol; 2010 Jan; 47(4):792-8. PubMed ID: 19896716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.